ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980